Pamela Garzone
Vermogen: 482 328 $ op 31-08-2026
Vermogen: 482 328 $ op 31-08-2026
Dr. Pamela D.
Garzone is an Independent Director at Cue Biopharma, Inc. and a Chief Development Officer at Anixa Biosciences, Inc. She is on the Board of Directors at Cue Biopharma, Inc., Centivax, Inc. and Temple Therapeutics, Inc. Dr. Garzone was previously employed as a Chief Medical Officer-Calibr by The Scripps Research Institute, a Vice President-Group Asset Team Lead by Pfizer Inc., and an Assistant Professor by University of Pittsburgh.
She received her undergraduate degree from Purdue University, a graduate degree from the University of Pittsburgh and a doctorate degree from the University of Pittsburgh.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,26% | 09-07-2026 | 18.900 ( 0,26% ) | 482 328 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ANIXA BIOSCIENCES, INC. | Corporate Officer/Principal | 07-09-2021 |
| CUE BIOPHARMA, INC. | Directeur/Bestuurslid | 19-04-2023 |
Centivax, Inc.
Centivax, Inc. BiotechnologyHealth Technology Operates as a vaccine clinical-stage company | Directeur/Bestuurslid | 01-09-2022 |
Temple Therapeutics Inc | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-05-2021 |
| PFIZER INC. | Corporate Officer/Principal | 01-05-2019 |
University of Pittsburgh
University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Anixa Biosciences, Inc.
Anixa Biosciences, Inc. BiotechnologyHealth Technology Develops therapies and vaccines for oncology and infectious disease | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Pittsburgh
University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Centivax, Inc.
Centivax, Inc. BiotechnologyHealth Technology Operates as a vaccine clinical-stage company | Health Technology |
Temple Therapeutics Inc |
Kies jouw editie
Alle financiële informatie op nationaal niveau